Drug intelligence / Profile preview

ibuprofen + phenylephrine hydrochloride

Development stage
Approved
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + phenylephrine hydrochloride is a fixed-dose combination pharmaceutical product used for the temporary relief of symptoms associated with the common cold, flu, and upper respiratory tract infections. It combines ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid derivative class, with phenylephrine hydrochloride, a sympathomimetic decongestant. Ibuprofen provides analgesic, antipyretic, and anti-inflammatory effects by non-selectively inhibiting the cyclooxygenase enzymes COX-1 and COX-2, thereby reducing the synthesis of pro-inflammatory prostaglandins. Phenylephrine hydrochloride acts as a selective alpha-1 adrenergic receptor agonist, causing vasoconstriction of the arterioles in the nasal mucosa, which leads to a reduction in swelling and congestion of the nasal passages. This combination is typically formulated as an immediate-release oral tablet and is widely available over-the-counter (OTC) in many regions, with various generic versions undergoing bioequivalence studies to match reference products like Advil Congestion Relief.

Brand names
Advil Congestion ReliefSudafed PE Head Congestion + PainDayQuil Pain & Congestion
Other names
ibuprofen and phenylephrine hydrochloride
02

Targets

Beyond the preview

Go deeper on ibuprofen + phenylephrine hydrochloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + phenylephrine hydrochloride.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call